The largest database of trusted experimental protocols

6 protocols using percp cyanine5.5 anti mouse cd45

1

Lung cell flow cytometry analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single cells were obtained from lungs digested by collagenase. The cells were stained for 1 h with abs PE Rat Anti-Mouse F4/80 (BD Pharmingen Cat# 565410), PE/Cy7 Anti-Mouse/Human CD11b (BioLegend Cat# 101215), PerCP/Cyanine5.5 Anti-Mouse CD45 (BioLegend Cat# 103132), and FITC Anti-Mouse Ly-6G/Ly-6C (Gr-1) (BioLegend Cat# 108406) diluted in PBS at a 1: 1,000. For compensation, single stained samples were set. Cells were analyzed on BD FACSymphony (BD). Data were generated using FlowJo V10 (Treestar, Stanford, CA).
+ Open protocol
+ Expand
2

Single-cell analysis of tumor immune cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The single cell suspensions were obtained followed protocol described previously. In brief, the primary tumors were dissociated in PBS with 1 mg/ml collagenase D and 4 μg/ml DNase I for 1 hour in 37 °C with periodic vortexing, and centrifuged at 500 g for 5–10 minutes, followed by removing red blood cells (RBC) by RBC lysis buffer. The cells were first blocked by anti-CD16/32 (101302, BioLegend) for 10 minutes to reduce nonspecific binding and then stained with following antibodies individually: PerCP/Cyanine5.5 anti-mouse CD45 (103131; BioLegend), PE anti-mouse NK-1.1 (108707; BioLegend), APC anti-mouse CD3 (100236; BioLegend), FITC anti-mouse CD69 (104505; BioLegend), FITC anti-human/mouse Granzyme B (515403; BioLegend), and FITC anti-mouse IFN-γ (505805; BioLegend). Zombie Violet™ Fixable Viability Kit (423113; BioLegend) was used to determine cell viability.
+ Open protocol
+ Expand
3

Characterization of Macrophage Polarization

Check if the same lab product or an alternative is used in the 5 most similar protocols
The spleen, peritoneal macrophages (PMs), and polarized peripheral blood mononuclear cells (pPBMC) were harvested and lysed with red blood cell lysing buffer (420,301; Biolegend). Cells were incubated with an Fc receptor blocker CD16/32 (eBioscience, San Diego, CA, USA) to reduce nonspecific antibody binding prior to adding staining antibodies. For live/dead cell separation 7-AAD (Invitrogen, Carlsbad, CA, USA) staining was used. Cells were labeled with APC anti-mouse F4/80, PerCP-Cyanine5.5 anti-mouse CD45, FITC anti-mouse CD11b, Brilliant Violet 421 anti-mouse CD206, Brilliant Violet 650 anti-mouse CD80 (clone BM8, clone 30-F11, clone M1/70, clone C068C2, and clone 16-10A1 respectively; Biolegend). For intracellular labeling, cells were stimulated with lipopolysaccharide (LPS) (10 μg/mL; Sigma–Aldrich, St. Louis, MO, USA), 3 μg/mL brefeldin A (Biolegend) for 5 h at 37 °C25 (link). The cells were stained with Brilliant Violet 605 anti-mouse IL-10, PE/Dazzle 594 tumor necrosis factor-alpha (TNF-α) (clone JES5-16E3 and clone 506,346, respectively; Biolegend), and PE anti-mouse inducible nitric oxide synthase (INOS) (clone CXNFT, respectively; eBioscience) and then analyzed using an CytoFLEX flow cytometer (Beckman Coulter, Miami, FL, USA). The data were analyzed by using FlowJo software (V.10.4, FlowJo, USA).
+ Open protocol
+ Expand
4

Multicolor Flow Cytometry Phenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single skin cells prepared above were stained with cell-surface antibodies for 30 min at 4 °C. Then, cell phenotyping was performed on a Cytoflex Flow Cytometer (Beckman Coulter, CA, USA). The cell-surface antibodies used were as follows: PE/Cyanine7 anti-mouse CD45 (103114, BioLegend), PerCP/Cyanine5.5 anti-mouse CD45 (103132, BioLegend), APC/Cyanine7 anti-mouse CD11b (557657, BD Pharmingen), APC anti-mouse CD64 (139306, BioLegend), PE anti-mouse Ly6C (128007, BioLegend), FITC anti-mouse Ly6G (127606, BioLegend), Brilliant Violet 421 anti-mouse CD3 (100336, BioLegend), Brilliant Violet 605 anti-mouse CD19 (115540, BioLegend), and Brilliant Violet 421 anti-mouse CD192 (CCR2) (150605, BioLegend).
+ Open protocol
+ Expand
5

Tumor Dissociation and Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumor tissues were harvested in RPMI Medium 1640 with 10% heat-inactivated FBS, 1% penicillin and streptomycin (all from HyClone™). Tumors were minced and incubated for 30 min in DPBS (Well-gene) with 0.5 mg/ml Collagenase IV (Sigma) at 37 °C. Tissues were squeezed through a 100 μm cell strainer (# 93100, SPL), re-filtered through a 70 μm cell strainer (# 93070, SPL) subjected for 5 min to Red Blood Cell Lysis Buffer (#10-548E, Lonza). Flow cytometry was performed to determine cell surface antigen expression by 30-min incubation on ice with pertinent antibodies. The following monoclonal antibodies were used: mouse-specific monoclonal antibodies used were PerCP/Cyanine5.5 anti-mouse CD45 (#103131, BioLegend), APC-anti-mouse CD8a (#100712, BioLegend) and corresponding isotype control mAbs PerCP/Cy5.5 Rat IgG2b (#400632, BioLegend) and APC Rat IgG2a (#400512, BioLegend). The cells were washed thrice with PBS containing 2% FBS and fixed in suspension with 4% paraformaldehyde and stored at 4 °C until analysis with a CytoFLEX flow cell counter (Beckman). We analyzed the data using FlowJo software.
+ Open protocol
+ Expand
6

Tumor Immune Profiling via Single-Cell Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single-cell suspensions from murine tumor tissues were prepared by mechanical and enzymatic disruption in PBS with 1 mg/ml collagenase D and 4 μg/ml DNase I for 1 h in 37 °C with periodic vortexing. Cells were filtered through a 70-um cell strainer, resuspended in PBS and centrifuged at 500 g for 5 min, followed by the removement of the red blood cells (RBCs) with RBC lysis buffer. The cells were blocked by 0.5% BSA for 30 min on ice with FC block and then stained with the following antibodies separately: PerCP/Cyanine5.5 anti-mouse CD45 (103,131; BioLegend), APC/Cyanine7 anti-mouse F4/80 (123,117; BioLegend), FITC anti-mouse CD3 (100,203; BioLegend), PE anti-mouse CD69 (104,507; BioLegend), APC anti-mouse CD206 (141,707; BioLegend), PE anti-mouse CD86 (105,007; BioLegend). APC anti-mouse CD8a (100,711; BioLegend). PE anti-mouse IFN-γ (505,807; BioLegend), PE anti-mouse PD-1 (135,205; BioLegend) and PE anti-mouse Ki67 (652,403; BioLegend). For intracellular staining, cells were first fixed (eBioscience, IC fixation buffer) and permeabilized (eBioscience, 1 × permeabilization buffer).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!